$CTNM News

Jones Trading Maintains Buy on Contineum Therapeutics, Raises Price Target to $30

Baird Downgrades Contineum Therapeutics to Neutral, Lowers Price Target to $14

All You Need to Know About Contineum Therapeutics, Inc. (CTNM) Rating Upgrade to Buy

Morgan Stanley Maintains Equal-Weight on Contineum Therapeutics, Lowers Price Target to $17

J&J and Contineum’s Depression Drug Missed Phase 2 Goal. What Comes Next?

Baird Maintains Outperform on Contineum Therapeutics, Lowers Price Target to $19

Contineum Therapeutics Reports Phase 2 Results for JNJ-5120/PIPE-307 for the Treatment of Major Depressive Disorder

Contineum Therapeutics to Present at the 2026 Morgan Stanley Global Healthcare Conference

Contineum, Disc Medicine, Recursion Advance Pipelines Ahead of Catalysts, Morgan Stanley Says

RBC Capital Maintains Outperform on Contineum Therapeutics, Raises Price Target to $23

Contineum Therapeutics Implements Workforce Reduction For Its Research Team Including Chief Scientific Officer Daniel Lorrain

Contineum Therapeutics Q2 EPS $(0.40) Beats $(0.48) Estimate

Are You Looking for a Top Momentum Pick? Why Contineum Therapeutics, Inc. (CTNM) is a Great Choice

Contineum Therapeutics Publishes Discovery of Potential Best-in-Class LPAR1 Antagonist PIPE-791 in Journal of Medicinal Chemistry

Contineum Therapeutics Publishes 'Discovery of PIPE-791, a Potent and Brain-Penetrant Lysophosphatidic Acid Receptor 1 (LPAR1) Antagonist with Slow Tight Binding Characteristics for the Treatment of Neuroinflammatory Disorders' In Journal of Medicinal Chemistry

Contineum Therapeutics to Present at the 2026 Goldman Sachs Global Healthcare Conference

Wall Street Analysts See a 59.96% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High?

Morgan Stanley Maintains Equal-Weight on Contineum Therapeutics, Raises Price Target to $16

Wall Street Analysts Think Contineum Therapeutics, Inc. (CTNM) Could Surge 49.21%: Read This Before Placing a Bet

Contineum Therapeutics Q1 EPS $(0.39) Beats $(0.51) Estimate